Originally published byEU-Startups
Resurrect Bio, a London-based agricultural BioTech startup developing disease-resistant crops, has closed its oversubscribed Series A funding round at €8.8 million ($10.3 million). In February 2026, the company made an initial close of over €6.8 million ($8 million) in its Series A round. The round was led by Corteva through its Corteva Catalyst platform, with […]
The post UK AgriBioTech startup Resurrect Bio closes €8.8 million Series A to develop disease-resistant crops appeared first on EU-Startups.
🌐
More news from European UnionEuropean Union
EUROPE
Related News
Europe’s AI future depends on UK-France-Germany DARPA alliance, says Nobel winner
16h ago
Earlybird raising €500m defence fund with French investor AVP, sources say
3h ago
Paris-based Prelude raises €17.2 million Series A to scale its onboarding and trust infrastructure platform
1d ago
London’s Searchable raises €11.9 million at €72.1 million valuation to help brands boost visibility across AI-led search
12h ago
Could Europe’s Red Tape finally be its Biggest Moat?
2d ago